Qiagen Investor Relations Material
Latest events
Q1 2025
Qiagen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Qiagen N.V.
Access all reports
Qiagen N.V. is a global biotechnology company specializing in sample and assay technologies for molecular diagnostics, life sciences research, and pharmaceutical development. The company provides solutions for DNA, RNA, and protein analysis, serving applications in disease detection, genetic research, and forensic testing. Qiagen’s products include reagents, instruments, and bioinformatics software used by healthcare providers, academic institutions, and biopharmaceutical companies. Qiagen N.V. is headquartered in Venlo, Netherlands, and its shares are listed on the NYSE and the Frankfurt Stock Exchange.
Key slides for Qiagen N.V.
Q1 2025
Qiagen N.V.
43rd Annual J.P. Morgan Healthcare Conference 2025
Qiagen N.V.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
QGEN
Country
🇺🇸 United States